Published in Mol Cell Biol on March 01, 1997
Requirement of bic/microRNA-155 for normal immune function. Science (2007) 16.24
Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A (2005) 12.96
MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A (2007) 11.42
Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol (2010) 7.75
MicroRNAs and cancer: short RNAs go a long way. Cell (2009) 7.25
microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity (2007) 6.72
Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A (2009) 5.30
Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res (2005) 4.86
Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep (2001) 4.74
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity (2008) 4.59
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol (2007) 4.19
Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe (2008) 3.14
Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res (2006) 2.93
RNAdb--a comprehensive mammalian noncoding RNA database. Nucleic Acids Res (2005) 2.84
Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome (2006) 2.64
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol (2008) 2.45
B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem (2007) 2.44
Analysis of the yeast genome: identification of new non-coding and small ORF-containing RNAs. Nucleic Acids Res (1997) 2.40
MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun (2009) 2.12
Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol (2008) 1.86
Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One (2009) 1.70
A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. J Virol (2008) 1.59
MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One (2009) 1.55
The role of microRNAs in cancer. Yale J Biol Med (2006) 1.54
Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res (2010) 1.40
Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA (2010) 1.39
miRNA regulation of cytokine genes. Cytokine (2009) 1.39
MicroRNA function in myeloid biology. Blood (2011) 1.30
Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol (2009) 1.28
MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol (2010) 1.23
MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood (2014) 1.19
Virus meets host microRNA: the destroyer, the booster, the hijacker. Mol Cell Biol (2014) 1.14
Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc Natl Acad Sci U S A (2013) 1.12
BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. J Exp Med (2012) 1.11
Translational and structural requirements of the early nodulin gene enod40, a short-open reading frame-containing RNA, for elicitation of a cell-specific growth response in the alfalfa root cortex. Mol Cell Biol (2001) 1.07
Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J Clin Invest (2011) 1.06
MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2014) 1.03
Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci (2009) 1.02
Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs. Cell Cycle (2011) 0.99
Long non-coding RNAs (lncRNAs) and viral infections. Biomed Pharmacother (2013) 0.98
OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes. PLoS Pathog (2013) 0.98
MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? J Cell Mol Med (2008) 0.97
miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett (2010) 0.96
Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. J Virol (2009) 0.92
Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus. J Virol (1997) 0.92
MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PLoS One (2013) 0.92
Non-coding RNAs revealed during identification of genes involved in chicken immune responses. Immunogenetics (2008) 0.91
MicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Investig (2010) 0.90
Micro-RNA Expression and Function in Lymphomas. Adv Hematol (2011) 0.90
High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer. Oncotarget (2015) 0.90
Physiological roles of miR-155. Immunology (2015) 0.89
Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice. Infect Immun (2012) 0.89
Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas. PLoS One (2011) 0.87
MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. J Steroid Biochem Mol Biol (2013) 0.85
Dexamethasone down-regulates the expression of microRNA-155 in the livers of septic mice. PLoS One (2013) 0.85
Myc oncogene-induced genomic instability: DNA palindromes in bursal lymphomagenesis. PLoS Genet (2008) 0.85
MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol (2013) 0.84
The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression. Transcription (2012) 0.81
Identification of microRNA in the developing chick immune organs. Immunogenetics (2009) 0.80
Pathogenic microRNA's in myeloid malignancies. Front Genet (2014) 0.80
Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. Neuro Oncol (2017) 0.80
Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas. MBio (2015) 0.79
Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death. Oncogene (2016) 0.79
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Cancer Sci (2017) 0.78
MicroRNA-155 is required for clearance of Streptococcus pneumoniae from the nasopharynx. Infect Immun (2014) 0.78
Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration. Oncotarget (2016) 0.77
Differential selection of cells with proviral c-myc and c-erbB integrations after avian leukosis virus infection. J Virol (1998) 0.77
Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells. Cancers (Basel) (2011) 0.77
Silencing of miR155 promotes the production of inflammatory mediators in Guillain-Barré syndrome in vitro. Inflammation (2013) 0.77
MicroRNAs as Biomarkers in Cancer. Diagnostics (Basel) (2013) 0.77
miR-155 induced transcriptome changes in the MCF-7 breast cancer cell line leads to enhanced mitogen activated protein kinase signaling. Genes Cancer (2014) 0.77
MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases. Inflammation (2016) 0.76
MicroRNAs in the Host Response to Viral Infections of Veterinary Importance. Front Vet Sci (2016) 0.76
Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma. PLoS One (2011) 0.76
Reduction of c-Fos via Overexpression of miR-34a Results in Enhancement of TNF- Production by LPS in Neutrophils from Myelodysplastic Syndrome Patients. PLoS One (2016) 0.75
MicroRNA miR-155 Is Necessary for Efficient Gammaherpesvirus Reactivation from Latency, but Not for Establishment of Latency. J Virol (2016) 0.75
Acute kidney injury and inflammatory response of sepsis following cecal ligation and puncture in d-galactose-induced aging rats. Clin Interv Aging (2017) 0.75
An RNAi-based approach to down-regulate a gene family in vivo. PLoS One (2013) 0.75
MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease. J Neuroinflammation (2016) 0.75
Cancer stem cell-associated microRNAs: searching for markers and targets in hepatocellular carcinoma. Transl Gastroenterol Hepatol (2016) 0.75
Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget (2016) 0.75
Integration of ALV into CTDSPL and CTDSPL2 genes in B-cell lymphomas promotes cell immortalization, migration and survival. Oncotarget (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A (1988) 193.60
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci U S A (1988) 35.13
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (1981) 17.31
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res (1987) 14.53
Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem (1991) 11.92
Requirement for Xist in X chromosome inactivation. Nature (1996) 8.24
The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell (1992) 8.05
Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell (1991) 7.16
Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. Mol Cell Biol (1987) 6.67
The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell (1992) 6.26
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63
The product of the H19 gene may function as an RNA. Mol Cell Biol (1990) 5.61
XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. J Cell Biol (1996) 5.51
Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell (1991) 5.02
Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach. Proc Natl Acad Sci U S A (1991) 4.63
Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A (1994) 4.53
Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science (1992) 4.42
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature (1991) 4.06
How the messenger got its tail: addition of poly(A) in the nucleus. Trends Biochem Sci (1990) 3.92
Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A (1993) 3.62
Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell (1989) 3.31
Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation. Cell (1993) 3.16
Tumour-suppressor activity of H19 RNA. Nature (1993) 3.06
Oligodeoxyribonucleotide ligation to single-stranded cDNAs: a new tool for cloning 5' ends of mRNAs and for constructing cDNA libraries by in vitro amplification. Nucleic Acids Res (1991) 3.01
Tumor suppression by RNA from the 3' untranslated region of alpha-tropomyosin. Cell (1993) 2.64
Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol (1989) 2.53
PKR: a new name and new roles. Trends Biochem Sci (1995) 2.33
Expression of Xist during mouse development suggests a role in the initiation of X chromosome inactivation. Cell (1993) 2.30
bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene (1993) 2.25
Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol Cell Biol (1991) 2.06
Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev (1991) 1.72
Tumorigenesis by slow-transforming retroviruses--an update. Biochim Biophys Acta (1990) 1.71
Loss of H19 imprinting in esophageal cancer. Cancer Res (1996) 1.60
The effect of alterations in myc gene expression on B cell development in the bursa of Fabricius. Cell (1987) 1.57
Pathogenesis of avian lymphoid leukosis. I. Histogenesis. J Natl Cancer Inst (1968) 1.54
X inactivation in mammalian testis is correlated with inactive X-specific transcription. Nat Genet (1992) 1.51
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol (1986) 1.42
Alternative readings of the genetic code. Cell (1993) 1.40
In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3' untranslated regions of human alpha-tropomyosin. Proc Natl Acad Sci U S A (1996) 1.39
A beginning to the biochemistry of polyadenylation. Trends Genet (1988) 1.35
Transgenic mice and oncogenesis. Annu Rev Immunol (1988) 1.34
Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci U S A (1995) 1.33
Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene (1995) 1.31
Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc Natl Acad Sci U S A (1991) 1.28
X chromosome inactivation and the Xist gene. Curr Opin Genet Dev (1994) 1.25
Formation of a transformed follicle is necessary but not sufficient for development of an avian leukosis virus-induced lymphoma. Proc Natl Acad Sci U S A (1985) 1.24
Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs. Biochimie (1994) 1.24
Oncogene co-operation in leukaemogenesis. Cancer Surv (1992) 1.20
A retroviral myc gene induces preneoplastic transformation of lymphocytes in a bursal transplantation assay. Proc Natl Acad Sci U S A (1985) 1.20
Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst (1994) 1.17
Unusual behavior of the cytoplasmic transcript of hsr omega: an abundant, stress-inducible RNA that is translated but yields no detectable protein product. J Cell Biol (1989) 1.16
Expression of Xist in mouse germ cells correlates with X-chromosome inactivation. Nat Genet (1992) 1.10
Expression of the X-inactivation-associated gene XIST during spermatogenesis. Nat Genet (1992) 1.07
The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J Biol Chem (1995) 1.03
Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations. Oncogene (1989) 1.00
Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl. Oncogene Res (1989) 0.94
Avian lymphoid leukosis: mechanisms of lymphomagenesis. Adv Vet Sci Comp Med (1988) 0.94
A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas. Oncogene (1992) 0.92
Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame. Mol Cell Biol (1994) 0.88
Retrovirus-induced B cell neoplasia in the bursa of Fabricius. Adv Immunol (1994) 0.87
Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice. Oncogene (1995) 0.86
Moloney virus induction of T-cell lymphomas in a plasmacytomagenic strain of E mu-v-abl transgenic mice. Int J Cancer (1993) 0.84
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (1981) 17.31
Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell (1981) 8.69
Size and genetic content of viral RNAs in avian oncovirus-infected cells. J Virol (1977) 5.00
An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell (1978) 4.66
Cellular information in the genome of recovered avian sarcoma virus directs the synthesis of transforming protein. Proc Natl Acad Sci U S A (1979) 3.66
Bacterial proteins required for replication of phage Q ribonucleic acid. Pruification and properties of host factor I, a ribonucleic acid-binding protein. J Biol Chem (1972) 3.45
Activation of the c-myc gene by translocation: a model for translational control. Proc Natl Acad Sci U S A (1983) 3.36
Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci U S A (1982) 3.02
Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus. Nature (1984) 2.93
Detection of avian tumor virus RNA in uninfected chicken embryo cells. J Virol (1973) 2.85
Characterization of the transforming gene of Fujinami sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.68
Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol (1989) 2.53
Genetic variation in the RNA transcripts of endogenous virus genes in uninfected chicken cells. J Virol (1977) 2.28
Recombination between endogenous and exogenous RNA tumor virus genes as analyzed by nucleic acid hybridization. J Virol (1975) 2.14
Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol (2001) 1.94
Nucleotide sequence 5' of the chicken c-myc coding region: localization of a noncoding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas. Proc Natl Acad Sci U S A (1984) 1.76
Molecular analysis of the c-myc locus in normal tissue and in avian leukosis virus-induced lymphomas. J Virol (1982) 1.70
Ten genetic loci in the chicken that contain structural genes for endogenous avian leukosis viruses. Cold Spring Harb Symp Quant Biol (1980) 1.63
Transcriptional products and DNA structure of endogenous avian proviruses. Cold Spring Harb Symp Quant Biol (1980) 1.62
Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proc Natl Acad Sci U S A (1984) 1.61
Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J Virol (1988) 1.61
Characterization of some isolates of newly recovered avian sarcoma virus. J Virol (1979) 1.51
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study. Leukemia (2008) 1.46
Localization of c-ras oncogene family on human germ-line chromosomes. Proc Natl Acad Sci U S A (1983) 1.46
The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles. Genes Dev (1990) 1.39
Laparoscopic splenectomy for immune thrombocytopenic purpura. J Laparoendosc Surg (1996) 1.39
Avian tumor virus proteins and RNA in uninfected chicken embryo cells. J Virol (1974) 1.38
Independent regulation of endogenous and exogenous avian RNA tumor virus genes. Proc Natl Acad Sci U S A (1976) 1.33
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood (1998) 1.30
Genetic determinants of neoplastic diseases induced by a subgroup F avian leukosis virus. J Virol (1987) 1.26
5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses. J Virol (1987) 1.25
Size and genetic content of virus-specific RNA in myeloblasts transformed by avian myeloblastosis virus (AMV). Virology (1981) 1.23
Induction of neoplasms by subgroup E recombinants of exogenous and endogenous avian retroviruses (Rous-associated virus type 60). J Virol (1980) 1.18
Localization of the cellular oncogenes ABL, SIS, and FES on human germ-line chromosomes. Cytogenet Cell Genet (1984) 1.17
Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia. Proc Natl Acad Sci U S A (1994) 1.12
Effect of the lambda repressor on the binding of RNA polymerase to DNA. Proc Natl Acad Sci U S A (1969) 1.10
Pheasant virus: new class of ribodeoxyvirus. Proc Natl Acad Sci U S A (1976) 1.09
Regulation of pyrimidine biosynthesis in Serratia marcescens. Proc Natl Acad Sci U S A (1965) 1.08
Retroviral gene expression. Curr Top Microbiol Immunol (1981) 1.08
CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies. Clin Radiol (2003) 1.07
Control expression of tumor virus genes in uninfected chicken cells. Cold Spring Harb Symp Quant Biol (1975) 1.05
Avian erythroblastosis virus produces two mRNA's. J Virol (1980) 1.04
Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients. Leukemia (2005) 1.04
Isolation of 16L virus: a rapidly transforming sarcoma virus from an avian leukosis virus-induced sarcoma. Proc Natl Acad Sci U S A (1982) 0.99
Inhibition of Escherichia coli and bacteriophage lambda messenger RNA synthesis by T4. Proc Natl Acad Sci U S A (1965) 0.95
Mechanisms of oncogenesis by subgroup F avian leukosis viruses. J Virol (1984) 0.95
CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma. Eur Radiol (2000) 0.94
Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma. J Virol (1997) 0.94
Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus. J Virol (1997) 0.92
ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. Blood (1999) 0.92
Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis (2009) 0.90
Absence of microsatellite instability during the progression of chronic myelocytic leukemia. Leukemia (1997) 0.89
Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol (2000) 0.88
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy. Leukemia (2011) 0.86
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin. J Rheumatol (1995) 0.86
Gaucher's disease affecting the mandible and maxilla. Report of a case. Int J Oral Maxillofac Surg (1991) 0.86
The association of inflammatory bowel disease and leukemia--coincidence or not? Leuk Lymphoma (1995) 0.85
Is chest CT sufficient for follow-up of primary mediastinal B-cell lymphoma in remission? AJR Am J Roentgenol (2002) 0.85
Molecular evolution of chronic myeloid leukaemia. Semin Cancer Biol (2001) 0.85
Germ-line chromosomal localization of genes in chromosome 11p linkage: parathyroid hormone, beta-globin, c-Ha-ras-1, and insulin. Somat Cell Mol Genet (1985) 0.84
Structural organization of upstream exons and distribution of transcription start sites in the chicken c-myb gene. Mol Cell Biol (1989) 0.84
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma (1993) 0.83
dup(10q) lacking alpha-satellite DNA in bone marrow cells of a patient with acute myeloid leukemia. Cancer Genet Cytogenet (1996) 0.83
Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms. Cancer (1999) 0.82
Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood (1997) 0.82
Preparation of a detailed restriction map of the avian leukosis virus MAV-2(O). Avian Dis (1990) 0.80
Translocation t(14;18) in healthy individuals: preliminary study of its association with family history and agricultural exposure. Ann Oncol (2000) 0.80
The tryphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res (1997) 0.79
Unresolved pneumonia due to endobronchial lipoma and actinomycosis. Eur Respir J (1989) 0.79
Candida abscess of the thyroid in a patient with acute lymphocytic leukemia. Eur J Med Res (1997) 0.78
Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin. Cell Death Dis (2013) 0.77
Massive intracranial bleeding requiring emergency splenectomy in a patient with CMV-associated thrombocytopenia. Haemostasis (1999) 0.77
ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL. Leukemia (2001) 0.76
Rapid induction of B-cell lymphomas by avian leukosis virus. Leukemia (1997) 0.76
Transforming protein encoded by the cellular information of recovered avian sarcoma viruses. Cold Spring Harb Symp Quant Biol (1980) 0.76
Prognostic significance of c-ABL methylation in chronic myelogenous leukemia: still an open question. Blood (1999) 0.75
Chronic eosinophilic pneumonia associated with cutaneous T-cell lymphoma. Am J Hematol (1999) 0.75
Absence of missense mutations in activated c-myc genes in avian leukosis virus-induced B-cell lymphomas. Mol Cell Biol (1988) 0.75
Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine. Leuk Res (1999) 0.75
Host proteins in the replication of bacteriophage RNA. Basic Life Sci (1973) 0.75
Hepatobiliary graft-versus-host disease manifested by common and hepatic biliary duct obstruction. Digestion (1997) 0.75
[Laparoscopic splenectomy for immune thrombocytopenic purpura]. Harefuah (1995) 0.75
Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia. Cancer Genet Cytogenet (1995) 0.75
The response to treatment in chronic idiopathic thrombocytopenic purpura (ITP). Southeast Asian J Trop Med Public Health (1993) 0.75
The role of host c-onc genes in viral and non-viral neoplasia. Prog Clin Biol Res (1983) 0.75
Expression of EBV encoded nuclear small non-polyadenylated RNA (EBER) molecules in 32 cases of childhood Burkitt's lymphoma from Israel. Leuk Lymphoma (2001) 0.75
Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy. Ann Pharmacother (1999) 0.75
Properties of phage lambda DNA-RNA polymerase complexes isolated from Escherichia coli (lambda). Biochim Biophys Acta (1970) 0.75
Avian lymphoid leukosis is correlated with the appearance of discrete new RNAs containing viral and cellular genetic information. Haematol Blood Transfus (1981) 0.75
A novel translocation (1;2)(p34;p21-22) in acute myelomonoblastic leukemia. Cancer Genet Cytogenet (1998) 0.75
Rearrangement and activation of the c-myc gene in avian and human B-cell lymphomas. Tumour Biol (1984) 0.75
Atypical presentation of Pneumocystis carinii pneumonia. Isr J Med Sci (1990) 0.75